TrialDiabetes care2012

Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: a 1-year, double-blind, randomized, controlled trial.

Peter J Curtis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.